© Copyright 2001-2023 Erowid Center. DrugsData is a project of
Erowid Center. All rights reserved.
By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center.
Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems.
This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.
Your javascript is turned off.
To remove this message, turn on javascript and accept the Terms of Use.
All samples analyzed by the DrugsData lab prior to early 2023 that were reported as containing Fluorexetamine have been reexamined in comparison to this new standard. They have all been retroactively revised; they all contain 2-Fluoro-2-oxo PCE, including this sample. To date, no samples tested by DrugsData have contained 3-Fluoro-2-oxo PCE.
It's important that samples submitted to this testing program be no more than 200 mg of material (ideally 20 to 50 mg). Keep in mind that just enough to *half* fill a capsule is more than enough. There is no advantage to sending more material, and samples that are too heavy may be delayed or require additional payment.
See how to send in a sample for testing.